Results 171 to 180 of about 165,524 (298)
Graves' disease with autoimmune hepatitis and primary Sclerosing cholangitis: an overlap syndrome. [PDF]
Pragathi LK +4 more
europepmc +1 more source
Metabolomics in autoimmune hepatitis: progress and perspectives. [PDF]
Huang X, Mo W, Wang X.
europepmc +1 more source
Safety of Immune Checkpoint Inhibitors Prior to Liver Transplantation in Hepatocellular Carcinoma
Patients who received immune checkpoint inhibitors before liver transplant for the treatment of hepatocellular carcinoma had rejection and survival outcomes comparable to those without ICI exposure. Most rejection episodes were effectively managed with medical therapy.
L. Aceituno +21 more
wiley +1 more source
Diagnostic and Therapeutic Challenges in Seronegative Autoimmune Hepatitis With Concurrent Graves Disease and Immune Thrombocytopenia. [PDF]
McLeod B +6 more
europepmc +1 more source
We conducted a nationwide, multicenter cohort study using a target trial emulation framework to compare baclofen and acamprosate in patients with compensated alcohol‐associated cirrhosis. After matching, baclofen initiation was associated with a higher 1‐year risk of major adverse liver outcomes, driven primarily by hepatic encephalopathy, particularly
Yee Hui Yeo +13 more
wiley +1 more source
Refractory autoimmune hepatitis in children: Considerations for assessment and management. [PDF]
Valamparampil J, Brown RM, McKiernan P.
europepmc +1 more source
In a retrospective cohort of 1,624 adults with cirrhosis, sarcopenia was independently associated with unplanned hospitalization, death, and cirrhosis progression (or death) in patients with decompensated disease. In compensated cirrhosis, sarcopenia was associated only with a higher risk of unplanned hospitalization.
Puneeta Tandon +12 more
wiley +1 more source
In ANA‐positive patients with suspected autoimmune hepatitis (AIH), liver biopsy rarely altered therapeutic management when alanine aminotransferase (ALT) was below 101 U/L and cirrhosis was absent. These findings suggest that biopsy may be safely deferred in this low‐risk group.
David Mehdi Asgher Niazi +8 more
wiley +1 more source
Efavirenz-Induced Hepatitis Mimicking Autoimmune Hepatitis: A Case Report. [PDF]
Chowdhury AH +4 more
europepmc +1 more source

